NOV stock may be overpriced given its limited growth forecas...

NOV stock may be overpriced given its limited growth forecasts, making its current P/S ratio ambitious. Slower revenue growth could potentially lower stock value despite solid past earnings growth. The weaker revenue outlook compared to the industry poses risks to share prices.